Researchers from the University of Notre Dame’s Keck Center for Transgene Research and trauma physicians at South Bend’s Memorial Hospital are joining forces to use a new medical technology to help save the lives of trauma patients. Researchers at the Keck Center investigate how the genes involved in blood clotting...

An interdisciplinary collaboration of six researchers, including four from Notre Dame, have received a three-year National Institutes of Health (NIH) grant to study the interplay of motility mechanisms during swarming of the bacterium Myxococcus xanthus. Their study is essential to understanding how millions of bacteria function in real environments. Mark...

Zachary Schafer, the Coleman Assistant Professor of Cancer Biology in the Department of Biological Sciences and a member of the Harper Cancer Research Institute at the University of Notre Dame, has been named a 2011 V Scholar by one of the nation’s leading cancer research fundraising organizations, the V Foundation...

NUT midline carcinoma (NMC) is a cancer without a cure, and one that affects all age groups. NMC is a rapid-growth disease with an average survival time of four and a half months after diagnosis, making the development of clinical trials for potential therapies or cures for this cancer difficult,...

Results of a study by a group of University of Notre Dame researchers represent a promising step on the road to developing new drugs for a variety of neurological diseases. The group from the University’s Departments of Chemistry and Biochemistry and Biological Sciences and the Freimann Life Sciences Center focused...